SelectScience InterviewsDrug discovery > Target Discovery
Open Innovation Platform: Advancing Healthcare Through Industrial and Academic Collaboration
4 Sept 2014
AstraZeneca’s new Open Innovation web portal will enable universities worldwide to partner with the company on new targets or chemical entities, through to ideas for clinical trials and late stage molecules. Dr. Peter Simpson explains how it is hoped that this will drive academic drug discovery research forward while improving the alliance between academic research and industry.
About the company
SelectScience
Established in July 1998, SelectScience is the fastest way to impartial, expert opinion about the best laboratory equipment and latest techniques.
